Advertisement

InFo Hämatologie + Onkologie

, Volume 22, Issue 9, pp 12–16 | Cite as

Schwerpunkt nichtkleinzelliges Lungenkarzinom

Aktuelle Aspekte der Chirurgie

  • Sönke von WeiheEmail author
Schwerpunkt
  • 7 Downloads

Die chirurgische Therapie des NSCLC ist in frühen Stadien die wesentliche Behandlungsoption. Aber auch bei fortgeschrittener Erkrankung kann sie andere Therapien sinnvoll ergänzen oder zur Symptomkontrolle eingesetzt werden. Lesen Sie mehr dazu in der folgenden Übersicht.

Literatur

  1. 1.
    Goldstraw P et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51CrossRefGoogle Scholar
  2. 2.
    Dienemann HC et al. (Hrsg). Chest Surgery. Berlin, Heidelberg: Springer-Verlag; 2015Google Scholar
  3. 3.
    Liehn et al. (Hrsg). OP-Handbuch. Berlin Heidelberg: Springer-Verlag; 2016Google Scholar
  4. 4.
    Alberg AJ et al. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl): e1S–e29SCrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Walters S et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax. 2013;68(6):551–64CrossRefPubMedGoogle Scholar
  6. 6.
  7. 7.
    Goeckenjan G et al. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie. 2011;65(1):39–59CrossRefPubMedGoogle Scholar
  8. 8.
    Harrison S et al. Do individual surgeon volumes affect outcomes in thoracic surgery? Eur J Cardiothorac Surg. 2019; http://doi.org/c84dGoogle Scholar
  9. 9.
    Jeon HW et al. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer. World J Surg Oncol. 2014;12:215CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tsutani Y et al. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2018;53(2):366–71CrossRefPubMedGoogle Scholar
  11. 11.
    Pravati AJ et al. Negative predictive value (NPV) of FDG PET-CT for nodal disease in clinically node-negative early stage lung cancer (AJCC 7th ed T1-2aN0) and identification of risk factors for occult nodal (pN1-N2) metastasis: implications for SBRT. Transl Cancer Res 2014;3:313–9Google Scholar
  12. 12.
    Stallard J et al. Is a sleeve lobectomy significantly better than a pneumonectomy? Interact Cardiovasc Thorac Surg. 2010;11(5):660–6CrossRefPubMedGoogle Scholar
  13. 13.
    Robinson LA et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):243S–65SCrossRefPubMedGoogle Scholar
  14. 14.
    Clive AO et al. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2016;(5):CD010529Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.ThoraxchirurgieLungenClinic Grosshansdorf GmbHGroßhansdorfDeutschland

Personalised recommendations